跳至主要内容
临床试验/NCT05245513
NCT05245513尚未招募不适用

Developing and Testing an Intervention to Enhance Recovery Capital Amid Opioid Use Disorder Pharmacotherapy: A Pilot Randomized Trial of Linkage to Recovery Support Services

Massachusetts General Hospital2 个研究点 分布在 1 个国家目标入组 145 人开始时间: 2025年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
145
试验地点
2
主要终点
Overall intervention acceptability

研究概览

简要总结

The aims of the current study are to: Aim 1. Develop and refine a novel intervention protocol for individuals receiving medication treatment for opioid use disorder that assertively links them to recovery community centers; Aim 2. Determine the feasibility, acceptability, and preliminary efficacy of assertive linkage to recovery community centers relative to a matched control condition, via a pilot randomized controlled trial; Aim 3. Explain quantitative findings by gaining an in-depth understanding of the intervention's feasibility, acceptability, and preliminary efficacy via qualitative interviews.

详细描述

This 5-year project seek to advance our understanding of the clinical and public health utility of recovery community centers and help bridge the gap between clinical treatment and community-based recovery support services. As a first step in this work, the investigators will develop and test a new intervention for peer-facilitated assertive linkage of patients receiving opioid use disorder pharmacotherapy to recovery community centers (RCCL), relative to a matched control condition (CC). This study aims to: Aim 1. Develop, manualize, and refine RCCL and CC protocols via stakeholder feedback. RCCL and CC protocols will be developed and manualized by adapting published community-based mutual-help linkage protocols. Upon preliminary manual development, feedback cycles will be conducted with relevant stakeholders (recovery coaches, recovery community center members, pharmacotherapy prescribers) to inform protocol revision, and promote its feasibility, acceptability, and adoptability. Aim 2. Determine the feasibility, acceptability, and preliminary efficacy of RCCL versus CC, via a pilot randomized controlled trial. More specifically, the feasibility of study procedures and RCCL/CC interventions, acceptability of interventions, and preliminary efficacy of RCCL relative to CC will be assessed. Aim 3. Explain quantitative findings by gaining an in-depth understanding of RCCL feasibility, acceptability, and efficacy via qualitative interviews in a subset of RCCL participants, peer facilitators, and linkage managers.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age ≥ 18 years
  • past-year opioid use disorder diagnosis per the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition
  • currently undergoing outpatient buprenorphine treatment through a provider or program at Massachusetts General Hospital
  • current residence in Massachusetts

排除标准

  • non-English fluency
  • active suicidality
  • neurodevelopmental disorders or neural trauma preventing informed consent
  • active psychosis
  • past-year attendance at a recovery community center or recovery support center

结局指标

主要结局

Overall intervention acceptability

时间窗: Month 1

Assessed via 1 single-item statement addressing the the acceptability of the intervention. The item is measured on a 6-point Likert scale (Strongly Disagree - Strongly Agree). Higher scores indicate greater acceptability.

Overall intervention satisfaction

时间窗: Month 1

Assessed via the Client Satisfaction Questionnaire-8 (CSQ8) total score. This is an 8 item measure of client satisfaction with services. Total scores range from 8 to 32, with higher scores indicating greater satisfaction.

Recovery community center attendance

时间窗: From the date of linkage manager meeting until the date of month-3 follow up, assessed up to 3 months

Percent of participants who attended a recovery community center 1+ time post linkage manager meeting, as assessed via the Timeline Follow Back

Overall intervention feasibility

时间窗: From the date of intervention manual finalization until the date of study completion, assessed up to 48 months

Assessed via the Feasibility: Intervention Implementation \& Training scale average total score. This is a 2-item instrument to assess perceived intervention feasibility. Items are measured on a 6-point Likert scale (Strongly Disagree-Strongly Agree). Score is the calculated mean. Higher scores indicate greater feasibility.

Fidelity: Linkage manager adherence

时间窗: From date of first linkage manager meeting until the date of last linkage manager meeting, assessed up to 36 months

Percent adherence of linkage managers to intervention protocols, as evaluated by the percentage of sessions that are scored with adequate adherence and assessed by recordings of intervention delivery and adherence evaluation materials developed as part of Aim 1 (e.g., adherence rating scales of critical topics). This is a 14-item instrument evaluating the extensiveness of linkage managers' delivery of critical intervention topics. Items are measured on a 5-point Likert scale (Not at all - Extensively). Score is the calculated mean. Total scores range from 1 to 5, with scores \> 3 indicating adequate adherence.

Use of recovery support services

时间窗: From the date of linkage manager meeting until the date of month-3 follow up, assessed up to 3 months

Percent days use of any recovery support services post linkage manager meeting, as assessed via the Timeline Follow Back

Overall recruitment feasibility

时间窗: Through study completion, ~3 years from recruitment initiation

Number of participants successfully recruited within allotted recruitment time frame (\~3 years)

次要结局

  • Intervention appropriateness(Month 1)
  • Change in recovery capital from baseline to Month 3(Baseline; Month 1; Month 3)
  • Participant retention(From the date of first participant enrollment in the trial to the date of study completion, up to 42 months)
  • Feasibility of peer facilitator meet-ups(Month 1; Month 3)
  • Intervention helpfulness(Month 1; Month 3)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lauren Hoffman

Principal Investigator

Massachusetts General Hospital

研究点 (2)

Loading locations...

相似试验